Buscar
Mostrando ítems 1-10 de 104
Philadelphia-negative chronic myeloproliferative neoplasms
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2012-01-01)
Chronic myeloproliferative diseases without the Philadelphia chromosome marker (Ph-), although first described 60 years ago, only became the subject of interest after the turn of the millennium. In 2001, the World Health ...
Acquired Von Willebrand Factor Abnormalities In Myeloproliferative Disorders And Other Hematologic Diseases: A Retrospective Analysis By A Single Institution
(Ferrata Storti Foundation, 2002-03)
Background and Objectives. Acquired von Willebrand syndrome (AVWS) is a rare acquired disorder. In most cases it is associated with lymphoproliferative disorders and monoclonal gammopathies, while less frequently ...
Assessment of platelet activation in myeloproliferative disorders with complementary techniques
(Lippincott Williams, 2004-04)
Bleeding and thrombosis in myeloproliferative disorders (MPD) are common events, sometimes both are present in the same patient during the course of the disease. Platelet activation in patients with MPD is often suggested. ...
Philadelphia-negative chronic myeloproliferative neoplasms
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2012)
A mutação JAK2 V617F e as síndromes mieloproliferativasJAK2 V617F mutation and the myeloproliferative disorders
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008)
Visceral mast cell tumor and mastocythemia in a dog
(2012-11-01)
Mast cell tumor manifests as a localized proliferation of mast cells in the skin, or less frequently as a systemic disorder, which may be accompanied by the presence of neoplastic mast cells in the peripheral blood ...
Estudo da função plaquetária em portadores de doenças mieloproliferativas crônicas
(Universidade Federal de São Paulo (UNIFESP), 1994)